|
|
F.E.C.C.I.A. Fédération Européenne des Cadres de la Chimie et des Industries Annexes 56, rue de Batignolles F-75017 PARIS tel.: 33 1 42 28 28 05 fax: 33 1 42 28 12 99 |
|
|
FECCIA Steering Committee Köln, on 29 September 2001 Statement of the President François Vincent
World and European Chemical Industry The optimism of the year 2000 has receded and numerous Chemical Companies have issued profit warnings since the beginning of the year. Declining results for the first half of 2001 and revisions to the forecast decline of results for the whole year are increasing, except for Groups with dominant pharmaceutical interests. The main reason is the increase of the oil price to 25 dollars per barrel, that increases the price of the chemical industry's raw materials. The slowing of American economic activity (with an exceptionally high gas price) entails a slowing of growth and pressure on prices as margins decrease on a long-term basis in all intermediate products with high energy content. The increase in the exchange rate of the euro against the dollar will slow down exports that are always a source of important income for the European Chemistry. The American Chemical Industry is expected to fall 0,3% (volume) this year, as well as the Japanese Chemical Industry 0,5%. The Asian Chemical Industry found again its dynamism with a growth of 7-8% in 2001 and 2002. In stock markets, as the new economy collapsed, Pharmaceuticals served a as refuge to investors. Another very solid sector was oil, where majors strengthened their positions in 2000 and continue to make important profits. Diversified Chemical Companies continue to report weak figures with stock values well below the leaders. The top five diversified chemical groups (Du Pont, Bayer, BASF, Dow, Akzo Nobel) have a stock value / turnover ratio of 1,3 while the top five mainly-pharmaceutical groups (Pfizer, Merck, GSK, J&J, Novartis) have the same ratio equal to 6,0. The Speciality Chemicals, launched with media fanfares, is not living up to its promises and concerned groups do not resist the current slowing of growth, as well as of the economic climate (rise of the cost of raw materials and energy). ICI, one of the original leaders of the world Chemical Industry, put up a good resistance and its CEO ensures that measures are taken in order that the Group improves its performances. Rhodia, previous number one of the French Chemical Industry, had a disappointing first half year. A new logo and corporate design have been developed for CEFIC. The former is to show the evolution of the organisation to one with dynamic attitude and objectives, reinforcing a new mode of work, more open and more direct with its members. Jean-Pierre Tirouflet, President of CEFIC, is resolutely optimistic for the growth of European chemical industry: 3,6% in 2000, 2% in 2001 and 3% in 2002. Restructurings Splits and mergers continue in all areas of the chemical industry (see annex) GlaxoSmithKline (GSK) is as big as Pfizer, number one of the pharmaceuticals. DuPont sold its oil sector at a bad moment. Dow is confident in its merger with Union Carbide, but transaction and restructuring costs are high (1,4 billion dollars). BASF sold its pharmaceuticals to the profit of the group Abbott with an exceptional appreciation of 6 billions euros on an amount of transfer of 6,9 billion dollars. Syngenta was created as world leader in Agrochemicals, with a great number of jobs suppressed. Aventis sold its Crop Science division to BAYER, after having abandoned the concept of "Life Sciences" and after the resignation of its CEO, Alain Godard. However Bayer, that wanted to preserve its diversified structure, was in difficulty because of problems with a drug and announced a change in strategy. Atofina is the result of the rearrangement of the chemical activities of Elf, Fina and Total with a reorganization in depth and the suppression of a research center. EON, which is refocussing on its energy activities, is ready to sell its chemical activity Degussa, born of the fusion of Degussa-Hüls and SKW Trostberg. Sanofi-Synthelabo displays a dynamic growth of its new products and L’Oréal continues to be a model Company in the sector of Cosmetics. Environment and health Chemicals has to face the emergence of new environment constraints coming from international regulations:
The United Nations Environment Programme (UNEP) works to protect human health and the environment world-wide, and UNEP Chemicals is the main catalytic force in the UN system for concerted global action on the environmentally sound management of hazardous chemicals. Located in Geneva, Switzerland, UNEP promotes sustainable development by catalysing vital global actions. On 22 May 2001, 127 governments adopted the Stockholm Convention on Persistent Organic Pollutants (POPs). POPs are chemicals that are persistent, bioaccumulate in fatty tissues, biomagnify through the food chain and adversely affect health and the environment. The adoption of the Convention and its subsequent signing by 92 parties signaled the end of negotiations that started in June 1998. These negotiations were called for in 1997 by the Governing Council of UNEP in recognition of the need for urgent global action to protect human health and the environment from POPs. The Convention seeks the elimination or restriction of production and use of all intentionally produced POPs (i.e., industrial chemicals and pesticides). Initially, the chemicals listed for elimination are aldrin, chlordane, dieldrin, endrin, heptachlor, hexachlorobenzene (HCB), mirex, toxaphene, polychlorinated biphenyls (PCBs). Continued use of DDT is allowed for vector control until safe, affordable and effec-tive alternatives are in place. Countries must make determined efforts to identify, label and remove PCB-containing equipment from use by 2025, and manage those wastes in an environmentally sound manner no later than 2028. The Convention also seeks the continuing minimization and, where feasible, ultimate elimination of the releases of unintentionally produced POPs such as dioxins and furans. Stockpiles and wastes containing POPs must be managed and disposed of in a safe, efficient and environmentally sound manner, taking into account international rules, standards and guidelines. Each Party is required to develop a plan for implementing its obligations under the Convention. The Convention also imposes certain trade restrictions, and has a procedure for adding other POPs. Governments have set up an interim financial mechanism, with the Global Environment Facility (GEF) as the principal entity, to assist developing countries and countries with economies in transition in their implementation of the treaty. The Commission sets out the path towards a sustainable use of chemicals On 13th February, 2001, the European Commission adopted a White Paper setting out the strategy for a future Community Policy for Chemicals. The main objective of the new Chemical Strategy is to ensure a high level of protection for human health and the environment, while ensuring the efficient functioning of the internal market and stimulating innovation and competitiveness in the chemical industry. Commenting on today's announcement Environment Commissioner Margot Wallström said: "This is one of the most important initiatives the Commission has taken in the context of sustainable development. We have decided on a step-by-step approach to phase out and substitute the most dangerous substances – the ones that cause cancer, accumulate in our bodies and in our environment and affect our ability to reproduce. This decision is crucial for future generations". Enterprise Commissioner Erkki Liikanen said: "Today's decision is crucial to get good and reliable information on the basis of which we can start analysing the many chemicals on the market on which we have no knowledge of their effects on the environment and our health. At the same time the decision is important to create a proper internal market for chemicals products – and thus a level playing field for our industry. The scheme which we have agreed today will also help stimulating innovation and will provide industry a clear framework within which they can work on a competitive footing with other global players. Chemical companies are anxiousOf the 30,000 chemical substances currently sold, 80% are produced in very small quantity (less than 100 tons per year) and are judged inoffensive. For these substances, manufacturers will have simply to bring "more information" by 2012, the European Commission white paper recommends. But, for 15% of these 30,000 products, i.e. approximately 5,000 substances manufactured in quantities over 100 tons and suspected to be potentially harmful, the future is quite different. To continue to sell some ethers, gas or chlorinated products, manufacturers will have, for example, to conduct thorough tests (by 2005 when the production exceeds 1,000 tons and by 2008 when it exceeds 100 tons) so as to prove that they are harmless in the long term. This will cost the manufacturers approximately 2 billion euros in total. For the remaining 5%, i.e. 1,500 products, a withdrawal or a severe restriction of marketing are already counselled by the white paper. It concerns substances judged potentially carcinogenic, eg asbestos or benzene, mutagenic or toxic to reproduction, or extremely polluting. The objective is to replace them rapidly by less harmful products. CEC / European Commission / European Parliament European Company Directive The European Parliament debated the proposed Directive on the European Company. The European Confederation of Managers (CEC) met the German Rapporteur Winfried Menrad to explain its position, and to insist on the capacity of specific representation of managers. It proposed amendments to achieve this. Corporate Social Responsibility : Green Paper Commission urges greater Corporate Social Responsibility in Europe Shortly after the European Commission's communication on quality of work, Commissioners Anna Diamantopoulou (Employment and Social Affairs) and Erkki Liikanen (Enterprise and Information Society) presented a Green Paper on promoting a European framework for Corporate Social Responsibility , whereby companies decide voluntarily to contribute to a better society. The paper, intended as a launch pad for debate, takes up the "triple bottom line" concept, whereby companies voluntarily take on board social and environmental concerns besides their economic ones. In line with the Commission's proposal for a Sustainable Development Strategy for Europe, recently endorsed by the Gothenburg European Council, the paper argues that all three elements can dovetail to create more productive and profitable business. Announcing its publication, Commissioners Diamantopoulou and Liikanen said, "More and more firms are realising the link between profitability and best ethical and environmental practice. Conscientious firms not only attract and retain the best workers, they can also get ahead in the technology game, vital for that all-important competitive edge." The paper is a direct contribution to the goal, backed by EU leaders at the March 2000 Lisbon European Council, of making the EU "the most competitive and dynamic knowledge-based economy in the world, capable of sustainable economic growth with more and better jobs and greater social cohesion." Part of this challenge lies in combining business profitability with the twin concepts of sustainability and accountability. It is also about striking the appropriate balance between flexibility and responsibility in creating a business-friendly environment. Protection of workers' personal data First stage consultation of social partners The purpose of this document is to consult the social partners, in accordance with Article 138, paragraph 2 of the EC Treaty, on the possible direction of a Community action on the protection of workers' personal data. Employers collect personal data on job applicants and workers for a number of purposes, including to comply with law, to assist in selection for employment, training and promotion, to ensure personal safety, personal security, quality control, customer service and the protection of property. Directive 95/46/EC fully applies to workers' personal data. However, it could be argued that, given the specific nature of the employment relationship and considering the general nature of the Directive, there may be a need for detailing out the application of the principles in the employment context. Financial participation: Consultation of CEC by the European Commission The Social Policy Agenda adopted by the European Commission on 28 June 2000 states (point 4.1.2.2) that a communication on financial participation and an action plan will be prepared in 2001. The purpose of financial participation is to associate a company’s employees with its profits and/or results. Financial participation schemes can take different forms. They may apply to senior managers or to all staff. The Commission is interested in particular in the schemes that apply to all a company’s workers or, at any rate, to the great majority. This paper classifies such schemes under three headings: profit sharing, share ownership and share options.
. Contacts with European Groups
FECCIA signed two protocols:
FECCIA was able to designate a manager CNC / NCK as member of the Special Group of Negotiation and signed the protocol of agreement. However, on the constitution of the Belgian delegation to the European Council, the CNC / NCK could not participate in the negotiation nor present a candidate. The President of FECCIA and the President of CNC/NCK have met the Belgian Direction of Human Resources, to attempt to find a solution, without success ! A meeting between a British AMPS member, manager in AstraZeneca and a member French of FCC, employee in the crop sector of Novartis, took place in Paris to prepare the merging of activities in the new Company Syngenta. Contacts have been continued during the constitution of the European Works Council of Syngenta. |
Annex
|
PRINCIPALES FUSIONS, ACQUISITIONS OU CESSIONS ANNONCEES OU FINALISEES EN 2000 |
||||||
|
SOCIETES CONCERNEES |
CA CONCERNE |
MONTANT DE LA TRANSACTION |
MARCHES ET OBJECTIFS DE L'OPERATION |
PAYS D'ORIGINE |
DATE DE L'ANNONCE |
DATE DE BOUCLAGE DE L'OPERATION |
|
Pfizer/ Warner Lambert |
30 Mrds $ |
90 Mrds $ |
Naissance du n°1 mondial ; croissance supérieure à 10%/an |
US/US |
1999 |
2000 |
|
Glaxo Welcome/ SmithKline Beecham |
25 Mrds $ |
- |
Naissance de GlaxoSmithKline (GSK), le coleader mondial de l'industrie pharmaceutique |
US/UK |
1999 |
2000 |
|
Pharmacia Upjohn/ Monsanto |
16,5 Mrds $ |
27 Mrds $ |
Le nouveau Pharmacia se recentre sur la pharmacie tandis que Monsanto met en Bourse son agrochimie |
US/US |
1999 |
2000 |
|
Dow Chemical/ Union Carbide |
24 Mrds $ |
11,6 Mrds $ |
Fusion des deux groupes chimiques |
US/US |
1999 |
Objectif Mars 2001 |
|
Sumitomo Chemical/ Mitsui Chemical |
16 Mrds $ |
joint-venture |
Création du n°1 de la chimie asiatique et n°5 mondial |
Jap./Jap. |
2000 |
2003 |
|
TotalFina/Elf |
16 Mrds $ |
joint-venture entre les maisons mères |
Création d'Atofina, 5ème chimiste mondial |
F/F |
1999 |
2000 |
|
Degussa Hüls/ SKW Trotsberg |
14 Mrds € |
12 Mrds € |
Constitution d'un "nouveau" Degussa qui se situe aux premières places mondiales de la chimie de spécialités |
D/D |
1999 |
2000 |
|
Abbott/Knoll |
2,6 Mrds $ |
6,9 Mrds $ |
Cession par BASF de sa pharmacie |
US/D |
2000 |
2000 |
|
Shire Pharma/ Biochem |
600 M $ |
4 Mrds $ |
Concentration dans la pharmacie |
UK/Can. |
2000 |
2000 |
|
Degussa/Laporte |
650 M € |
2,3 Mrds € |
Degussa se renforce dans la chimie fine, notamment pour la pharmacie |
D/UK |
2000 |
2001 |
|
Clariant/BTP |
500 M $ |
1,8 Mrds $ |
Renforcement dans la chimie fine pharmaceutique et agrochimique |
CH/UK |
2000 |
2000 |
|
Invitrogen/Dexter |
500 M $ |
1,78 Mrds $ |
Acquisition de technologies pharmaceutiques |
US/US |
2000 |
2000 |
|
AEA Investors/ Goodrich Performance Materials |
1,2 Mrds $ |
1,4 Mrds $ |
Acquisition par un groupe financier |
US/US |
2000 |
2001 |
|
Rhodia/ Albright & Wilson |
6 Mrds $ |
1,1 Mrds $ |
Position de leader mondial dans les phosphates |
F/UK |
1999 |
2000 |
|
BP Amoco/ Burmah Castrol |
4,3 Mrds $ (Burma Cast.) |
4,7 Mrds $ |
Acquisition d'activités dans les lubrifiants et la chimie de spéc. |
UK/UK |
2000 |
2000 |
|
Chevron/Philips |
6 Mrds $ |
joint-venture dans la chimie |
Constitution d'un groupe de taille mondiale dans la pétrochimie, les oléfines, les aromatiques, les matières plastiques |
US/US |
2000 |
2000 |
|
BASF/ Shell Chemicals |
6 Mrds $ |
joint-venture dans les polyoléfines |
Basell devient le leader mondial des polyoléfines |
D/UK/NL |
1999 |
2000 |
|
Linde/Aga |
1,8 Mrds € |
3,5 Mrds € |
Concentration dans les gaz industriels |
D/S |
1999 |
2000 |
|
BP Chemicals/ Solvay |
2,5 Mrds € |
Cession du PP et joint-venture dans le PEHD |
Solvay sort du PP et met son PEHD en JV avec BP |
UK/B |
2000 |
2001 |
|
Rhodia/Chirex |
150 M $ |
0,5 Mrd $ |
Renforcement de Rhodia dans la chimie fine pharmaceutique |
F/US |
2000 |
2000 |
|
DSM/Catalytica |
450 M $ |
800 M $ |
DSM se renforce dans la chimie fine pharmaceutique sur le marché US |
NL/US |
2000 |
2001 |
|
IFF/BBA |
2 Mrds $ |
970 M $ |
Acquisition qui permet à IFF de repasser en n°1 devant de repasser en n°1 devant Givaudan |
US/US |
2000 |
2001 |
|
Novartis/AstraZeneca |
7 Mrds $ |
joint-venture |
Devient le leader détaché en agrochimie et n°3 en semences. Permet à Norvartis et AstraZeneca de sortir de l'agrochimie |
CH/UK |
1999 |
2000 |
|
Sasol/Condea |
4 Mrds $ |
1,16 Mrds $ |
Leader mondial des tensio-actifs, avec une bonne intégration amont |
SA/D |
2000 |
2001 |
|
ICI/activités chimiques |
cessions |
Env. 1 Mrd € |
Méthanol à Methanex Participation dans HICI à Huntsman. Chlore et HFC à Ineos |
UK/Can. /UK/UK |
1999 |
2000 |
|
Pierre Fabre/BioMérieux |
1,75 Mrds € |
joint-venture |
Création d'un groupe présent dans le médicament, la dermo-cospique, le diagnostic, l'homéopathie |
F/F |
2000 |
2001 |
|
Wacker/Wacker |
3 Mrds € |
n.c. |
Cession à la famille Wacker par Aventis de sa participation de 50 % dans le groupe Wacker |
D/D |
2000 |
2001 |
|
Bayer/ polyols de Lyondell |
2,45 Mrds $ |
Renforce les positions de Bayer dans le PUR |
D/US |
1999 |
2000 |
|
|
KKR/Chimie de spécial. de Laporte |
726 M $ |
1,18 Mrd $ |
Acquisition par un groupe financier |
US/UK |
2000 |
2000 |
|
Morgan Grenfell/ epoxy de Ciba |
1 Mrd $ |
950 M $ |
Acquisition par un groupe financier |
D/CH |
1999 |
2000 |
|
Industri Kapital/Dyno |
1,2 Mrd $ |
595 M $ |
Acquisition par un groupe financier |
N/N |
1999 |
2000 |